Syneos Health to Share Critical Insights for Maximizing Value and Fueling Commercial Success at Biotech Showcase Events
Executives from the company’s market-leading clinical and commercial organizations will be on hand and participate in three panels during the events, which run parallel to the
“Scientific advances are leading to a surge in breakthrough medicines and digital therapies at a time when biopharmaceutical companies are facing an even more uncertain pricing and reimbursement environment,” said
The Booming Biotech Ecosystem: The Playing Field has Evolved, and the Bases Are Loaded. How
To Spend or Not to Spend: Investing for Commercial Success as an
Executives at emerging companies need to understand what levels of spend are appropriate to prepare for a successful product launch whether the plan is to partner, out-license or go it alone.
Pioneers and New Frontiers: Technologies Positioned to Change the Future and Blazing a Trail Toward Commercialization
Veteran digital and brand strategist Baba Shetty, Chief Strategy Officer,
- To further explore these topics and the critical shifts the industry faces in 2019, download the Company’s Health Trend Ten ebook or podcast, which provides biopharma decision makers with what’s-next insights to navigate challenges and capitalize on opportunities ahead.
Syneos Healthon LinkedIn or Twitter for live updates from the Company’s Biotech Showcase and Digital Medicine & Medtech Showcase panels.
|Ronnie Speight||Danielle DeForge|
|Senior Vice President, Investor Relations||Executive Director, External Communications|
|+1 919 745 2745||+1 202 210 5992|
Source: Syneos Health